BioJet LLC has obtained a license from the Ministry of Industry and Trade of Russia granting it the right to manufacture medicinal products for medical use and/or drugs for clinical trials (testing).
In addition, the company’s production facility has received a GMP certificate, confirming its compliance with the Good Manufacturing Practice standards of the Eurasian Economic Union.
On April 24, BioJet took part in the “TechnoWORK” recruitment event held at the Pechatniki…
Russian Deputy Prime Minister Tatyana Golikova announced the first results of the national project “New…
In 2025, venture funding in the biotechnology sector continued its recovery trend that began the…
The retail market for veterinary drugs in Russia increased by 17.7% in value terms in…
The Russian government has amended a resolution on the distribution of responsibilities among federal agencies…
